Market movers: UnitedHealth Group, GE Aerospace, RTX Corporation, Lucid Group…

The cleanest read-through is that the market is rewarding balance-sheet resilience and pricing power over pure top-line growth. UNH and GE are the highest-quality signals here: both are effectively telling the market that cost inflation is being absorbed better than feared, which tends to compress risk premia across managed care and aerospace suppliers rather than just lift the individual names. That matters for second-order positioning because it supports a rotation into “self-help plus visibility” compounders while leaving lower-quality cyclicals vulnerable if investors conclude margin durability matters more than nominal growth.

RTX’s beat is more important than the headline suggests because defense exposure is now increasingly being re-rated through the lens of backlog conversion and aftermarket mix, not just defense spending growth. If commercial engines and services are accelerating this fast, the broader aerospace supply chain should see tighter lead times and firmer pricing power into 2H26, which is positive for tier-two suppliers but also raises the bar for airlines and OEMs on costs. The risk is that the market extrapolates one quarter into a straight-line recovery; any hiccup in engine shop visits, delivery cadence, or export timing would hit sentiment quickly over the next 1-2 quarters.

LCID remains a financing narrative masquerading as a product narrative. Uber’s incremental capital is supportive near term, but the real implication is that strategic investors are being used as a bridge to extend runway and optionality; that often inflates the equity for days, not months, unless unit economics visibly improve. The contrarian angle is that the market may be overpricing takeover speculation while underpricing dilution risk and the likelihood that any eventual strategic solution happens at a discount to today’s price.